![](/images/general/no_picture/200_user.png)
David M Naff
Examiner (ID: 17706)
Most Active Art Unit | 1651 |
Art Unit(s) | 1302, 1643, 1657, 1208, 1808, 1207, 1803, 1802, 1651, 2899 |
Total Applications | 2218 |
Issued Applications | 1396 |
Pending Applications | 143 |
Abandoned Applications | 679 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 16891983
[patent_doc_number] => 11033509
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-06-15
[patent_title] => Pharmaceutical bead formulations comprising dimethyl fumarate
[patent_app_type] => utility
[patent_app_number] => 16/076849
[patent_app_country] => US
[patent_app_date] => 2017-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 23715
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 187
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16076849
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/076849 | Pharmaceutical bead formulations comprising dimethyl fumarate | Feb 7, 2017 | Issued |
Array
(
[id] => 11713543
[patent_doc_number] => 20170182042
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-06-29
[patent_title] => 'PHARMACEUTICAL COMPOSITIONS OF 7-(6-(2-HYDROXYPROPAN-2-YL)PYRIDIN-3-YL)-1-((TRANS)-4-METHOXYCYCLOHEXYL)-3,4-DIHYDROPYRAZINO [2,3-B]PYRAZIN-2(1H)-ONE, A SOLID FORM THEREOF AND METHODS OF THEIR USE'
[patent_app_type] => utility
[patent_app_number] => 15/427242
[patent_app_country] => US
[patent_app_date] => 2017-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 61672
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15427242
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/427242 | Pharmaceutical compositions of 7-(6-(2-hydroxypropan-2-yl)pyridin-3-yl)-1-((trans)-4-methoxycyclohexyl)-3,4-dihydropyrazino [2,3-B]pyrazin-2(1H)-one, a solid form thereof and methods of their use | Feb 7, 2017 | Issued |
Array
(
[id] => 11647861
[patent_doc_number] => 20170143761
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-05-25
[patent_title] => 'METHODS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH INFECTION AND/OR INFLAMMATION'
[patent_app_type] => utility
[patent_app_number] => 15/425206
[patent_app_country] => US
[patent_app_date] => 2017-02-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 12823
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15425206
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/425206 | METHODS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH INFECTION AND/OR INFLAMMATION | Feb 5, 2017 | Abandoned |
Array
(
[id] => 12857698
[patent_doc_number] => 20180177740
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-06-28
[patent_title] => NON-NATURAL FIBER OR FILAMENT WITH HERBAL RESIDUE AND METHOD OF MAKING THE SAME
[patent_app_type] => utility
[patent_app_number] => 15/424851
[patent_app_country] => US
[patent_app_date] => 2017-02-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2511
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15424851
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/424851 | NON-NATURAL FIBER OR FILAMENT WITH HERBAL RESIDUE AND METHOD OF MAKING THE SAME | Feb 4, 2017 | Abandoned |
Array
(
[id] => 15483265
[patent_doc_number] => 10556965
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-02-11
[patent_title] => Methods and materials for treating cancer
[patent_app_type] => utility
[patent_app_number] => 15/417721
[patent_app_country] => US
[patent_app_date] => 2017-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 33
[patent_figures_cnt] => 30
[patent_no_of_words] => 8662
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 106
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15417721
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/417721 | Methods and materials for treating cancer | Jan 26, 2017 | Issued |
Array
(
[id] => 17080442
[patent_doc_number] => 20210275448
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-09
[patent_title] => CARRIER FOR THE ORAL ABSORPTION OF AN ACTIVE SUBSTANCE BY ANIMALS, METHOD FOR PREPARING SAME AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/319656
[patent_app_country] => US
[patent_app_date] => 2017-01-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5447
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16319656
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/319656 | Carrier for the oral absorption of an active substance by animals, method for preparing same and uses thereof | Jan 19, 2017 | Issued |
Array
(
[id] => 11618310
[patent_doc_number] => 20170128497
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-05-11
[patent_title] => 'CO-ENCAPSULATION OF LIVE CELLS WITH OXYGEN-GENERATING PARTICLES'
[patent_app_type] => utility
[patent_app_number] => 15/411351
[patent_app_country] => US
[patent_app_date] => 2017-01-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 4546
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15411351
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/411351 | Co-encapsulation of live cells with oxygen-generating particles | Jan 19, 2017 | Issued |
Array
(
[id] => 11820445
[patent_doc_number] => 20170209382
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-07-27
[patent_title] => 'Materials with Water-Triggered Drug-Release Properties for Localized Therapeutics'
[patent_app_type] => utility
[patent_app_number] => 15/408014
[patent_app_country] => US
[patent_app_date] => 2017-01-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 4595
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15408014
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/408014 | Materials with water-triggered drug-release properties for localized therapeutics | Jan 16, 2017 | Issued |
Array
(
[id] => 14258739
[patent_doc_number] => 10278913
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-05-07
[patent_title] => Oil-based eyelash cosmetic and cosmetic method
[patent_app_type] => utility
[patent_app_number] => 16/070026
[patent_app_country] => US
[patent_app_date] => 2017-01-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6709
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 114
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16070026
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/070026 | Oil-based eyelash cosmetic and cosmetic method | Jan 12, 2017 | Issued |
Array
(
[id] => 17192353
[patent_doc_number] => 11161088
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-11-02
[patent_title] => O2 scavenging CaCO3 treatment
[patent_app_type] => utility
[patent_app_number] => 15/780501
[patent_app_country] => US
[patent_app_date] => 2017-01-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 10
[patent_no_of_words] => 17116
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 134
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15780501
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/780501 | O2 scavenging CaCO3 treatment | Jan 11, 2017 | Issued |
Array
(
[id] => 13659015
[patent_doc_number] => 10159649
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-12-25
[patent_title] => Controlled release delivery device comprising an organosol coat
[patent_app_type] => utility
[patent_app_number] => 15/399010
[patent_app_country] => US
[patent_app_date] => 2017-01-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 15582
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 107
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15399010
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/399010 | Controlled release delivery device comprising an organosol coat | Jan 4, 2017 | Issued |
Array
(
[id] => 12542925
[patent_doc_number] => 10010508
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2018-07-03
[patent_title] => MTAB-TA-Coated gold nanorods and method of fabrication
[patent_app_type] => utility
[patent_app_number] => 15/379581
[patent_app_country] => US
[patent_app_date] => 2016-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 38
[patent_no_of_words] => 5846
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15379581
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/379581 | MTAB-TA-Coated gold nanorods and method of fabrication | Dec 14, 2016 | Issued |
Array
(
[id] => 11864624
[patent_doc_number] => 20170231909
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-17
[patent_title] => 'FOAM PREPARED FROM NANOEMULSIONS AND USES'
[patent_app_type] => utility
[patent_app_number] => 15/368236
[patent_app_country] => US
[patent_app_date] => 2016-12-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 22079
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15368236
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/368236 | FOAM PREPARED FROM NANOEMULSIONS AND USES | Dec 1, 2016 | Abandoned |
Array
(
[id] => 14002735
[patent_doc_number] => 10219789
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-03-05
[patent_title] => Systems, methods, and devices for assessing microbiota of skin
[patent_app_type] => utility
[patent_app_number] => 15/366811
[patent_app_country] => US
[patent_app_date] => 2016-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 37
[patent_no_of_words] => 44771
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 126
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15366811
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/366811 | Systems, methods, and devices for assessing microbiota of skin | Nov 30, 2016 | Issued |
Array
(
[id] => 12343332
[patent_doc_number] => 09949941
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-04-24
[patent_title] => GABA analog prodrug sustained release oral dosage forms
[patent_app_type] => utility
[patent_app_number] => 15/359321
[patent_app_country] => US
[patent_app_date] => 2016-11-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 9
[patent_no_of_words] => 9211
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 135
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15359321
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/359321 | GABA analog prodrug sustained release oral dosage forms | Nov 21, 2016 | Issued |
Array
(
[id] => 11625846
[patent_doc_number] => 20170136035
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-05-18
[patent_title] => 'PROCESS FOR PREPARING A DRY POWDER FORMULATION COMPRISING AN ANTICHOLINERGIC, A CORTICOSTEROID AND A BETA-ADRENERGIC'
[patent_app_type] => utility
[patent_app_number] => 15/351562
[patent_app_country] => US
[patent_app_date] => 2016-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10919
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15351562
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/351562 | Process for preparing a dry powder formulation comprising an anticholinergic, a corticosteroid and a beta-adrenergic | Nov 14, 2016 | Issued |
Array
(
[id] => 11625845
[patent_doc_number] => 20170136034
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-05-18
[patent_title] => 'PROCESS FOR PREPARING A DRY POWDER FORMULATION COMPRISING AN ANTICHOLINERGIC, A CORTICOSTEROID AND A BETA-ADRENERGIC'
[patent_app_type] => utility
[patent_app_number] => 15/351510
[patent_app_country] => US
[patent_app_date] => 2016-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10336
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15351510
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/351510 | Process for preparing a dry powder formulation comprising an anticholinergic, a corticosteroid and a beta-adrenergic | Nov 14, 2016 | Issued |
Array
(
[id] => 15880235
[patent_doc_number] => 10646440
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-05-12
[patent_title] => Sanguisorbigenin polymer micelle and preparative methods thereof
[patent_app_type] => utility
[patent_app_number] => 16/095140
[patent_app_country] => US
[patent_app_date] => 2016-11-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3377
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16095140
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/095140 | Sanguisorbigenin polymer micelle and preparative methods thereof | Nov 6, 2016 | Issued |
Array
(
[id] => 13573887
[patent_doc_number] => 20180338492
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-11-29
[patent_title] => IMPROVED BIOCIDE COMPOSITIONS BASED ON MAGNESIUM FLUORIDE AS WELL AS USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 15/771761
[patent_app_country] => US
[patent_app_date] => 2016-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3790
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -30
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15771761
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/771761 | IMPROVED BIOCIDE COMPOSITIONS BASED ON MAGNESIUM FLUORIDE AS WELL AS USES THEREOF | Oct 25, 2016 | Abandoned |
Array
(
[id] => 11512903
[patent_doc_number] => 20170079976
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-03-23
[patent_title] => 'INJECTABLE FLOWABLE COMPOSITION COMPRISING BUPRENORPHINE'
[patent_app_type] => utility
[patent_app_number] => 15/334000
[patent_app_country] => US
[patent_app_date] => 2016-10-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 19138
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15334000
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/334000 | Injectable composition comprising buprenorphine | Oct 24, 2016 | Issued |